<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01493674</url>
  </required_header>
  <id_info>
    <org_study_id>HULP 2448</org_study_id>
    <secondary_id>2007-004353-28</secondary_id>
    <nct_id>NCT01493674</nct_id>
  </id_info>
  <brief_title>Folic Acid Supplementation in Eating Disorder</brief_title>
  <official_title>Folic Acid Supplementation for Improving Homocysteine Levels, Cognitive and Depressive Status in Eating Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to determine the effect of folic acid supplementation on
      homocysteine levels in a group of patients with eating disorders (ED) with low folate intake.
      The secondary aims were to evaluate the evolution on cognitive and depressive status after
      the intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Some authors have identified the presence of increased levels of homocysteine in patients
      with eating disorders and attempts have been made to find some association between this and
      the high rates of depression and cognitive function impairment recorded in these patients. It
      is still not known what causes this increase in homocysteine levels, whether the levels
      return to normal after the nutritional state is normalised and what strategies must be
      employed to carry out this normalisation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood variables monitored</measure>
    <time_frame>after 6 month of intervention</time_frame>
    <description>serum folate, red blood cell folate, vitamin B12, plasma homocysteine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution on cognitive and depressive status</measure>
    <time_frame>after 6 month of intervention</time_frame>
    <description>Beck Depression Inventory Test Stroop colour-word interference test Trail Making Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric parameters</measure>
    <time_frame>after 6 month of intervention</time_frame>
    <description>weight, body composition, food frequency questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary parameters</measure>
    <time_frame>after 6 months of intervention</time_frame>
    <description>Energy, macronutrients and micronutrients intake.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Eating Disorders</condition>
  <arm_group>
    <arm_group_label>placebo tablets</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>two identical tablets, but composed of crystalline cellulose, lactose and colouring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>a suplemented group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>two 5-mg tablets of folic acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>folic acid</intervention_name>
    <description>two 5-mg tablets of folic acid</description>
    <arm_group_label>a suplemented group</arm_group_label>
    <other_name>folic acid (ACFOL®)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females diagnosed with eating disorders (DSM-IV criteria of the American
             Psychiatric Association, 2000)

          -  Age &gt; 18 years

          -  Low folate intake based on the recommended daily intake in terms of age (Institute of
             Medicine, 1998)

        Exclusion Criteria:

          -  Patients with contraindications for folic acid supplementation due to hypersensitivity
             to folic acid or anaemia due to lack of B12

          -  Patients who routinely used drugs that interfere with folic acid absorption
             (analgesics, anticonvulsants, hydantoin, carbamazepine, antacids, antibiotics,
             cholestyramine, methotrexate, pyrimethamine, triamterene, trimethoprim and
             sulphonamides)

          -  Patients with vitamin and mineral supplements intake.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmen Gómez Candela, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nutrition Department. La Paz University Hospital. La Paz Health Research Institute.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>December 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2011</study_first_posted>
  <last_update_submitted>December 14, 2011</last_update_submitted>
  <last_update_submitted_qc>December 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz</investigator_affiliation>
    <investigator_full_name>Ignacio Galicia</investigator_full_name>
    <investigator_title>Head of Research and Clinical Trial Department</investigator_title>
  </responsible_party>
  <keyword>folate</keyword>
  <keyword>homocysteine</keyword>
  <keyword>cognitive function</keyword>
  <keyword>eating disorders</keyword>
  <keyword>depression.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

